Early evidence of the effectiveness of the human papillomavirus vaccination program against anogenital warts in Manitoba, Canada: a registry cohort study

K Willows, S Bozat-Emre, CH Righolt… - Sexually transmitted …, 2018 - journals.lww.com
Background We assessed the effectiveness of the quadrivalent human papillomavirus
vaccine (qHPV) vaccination program in Manitoba, Canada, in reducing incident anogenital …

Early Evidence of the Effectiveness of the Human Papillomavirus Vaccination Program Against Anogenital Warts in Manitoba, Canada

K Willows, S Bozat-Emre, CH Righolt, EV Kliewer… - Sexually Transmitted …, 2018 - JSTOR
Background: We assessed the effectiveness of the quadrivalent human papillomavirus
vaccine (qHPV) vaccination program in Manitoba, Canada, in reducing incident anogenital …

Early Evidence of the Effectiveness of the Human Papillomavirus Vaccination Program Against Anogenital Warts in Manitoba, Canada: A Registry Cohort Study

K Willows, S Bozat-Emre, CH Righolt… - Sexually …, 2018 - pubmed.ncbi.nlm.nih.gov
Background We assessed the effectiveness of the quadrivalent human papillomavirus
vaccine (qHPV) vaccination program in Manitoba, Canada, in reducing incident anogenital …

Early evidence of the effectiveness of the human papillomavirus vaccination program against anogenital warts in Manitoba, Canada: a registry cohort study.

K Willows, S Bozat-Emre, CH Righolt, EV Kliewer… - 2018 - cabidigitallibrary.org
Background: We assessed the effectiveness of the quadrivalent human papillomavirus
vaccine (qHPV) vaccination program in Manitoba, Canada, in reducing incident anogenital …

Early Evidence of the Effectiveness of the Human Papillomavirus Vaccination Program Against Anogenital Warts in Manitoba, Canada: A Registry Cohort Study.

K Willows, S Bozat-Emre, CH Righolt… - Sexually Transmitted …, 2018 - europepmc.org
BACKGROUND: We assessed the effectiveness of the quadrivalent human papillomavirus
vaccine (qHPV) vaccination program in Manitoba, Canada, in reducing incident anogenital …